Category Specific RSS

biotech

Alterity Therapeutics moves neuroprotective drug to Phase 2 trials

Seven to ten years. That’s how long someone diagnosed with multiple system atrophy (MSA) has to live from when symptoms…

3 years ago

Cynata to tackle common transplant side effect with lead drug CYP-001

The first successful organ donation occurred in 1954 where a living donor gave a kidney to his identical twin. Since…

3 years ago

Top biotech dealmaker appointed Chairman of Crowd Media

When one of Europe’s top executives has his previous business sold for $830 million and accepts a role to lead…

3 years ago

Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch

“How much does it hurt, on a scale of 1-10?” Easily the most frustratingly vague of medical questions due to…

3 years ago